8-K//Current report
Aspire Biopharma Holdings, Inc. 8-K
Accession 0001493152-25-018512
$ASBPCIK 0001847345operating
Filed
Oct 16, 8:00 PM ET
Accepted
Oct 17, 5:15 PM ET
Size
258.5 KB
Accession
0001493152-25-018512
Documents
- 8-Kform8-k.htmPrimary
8-K
- EX-101.SCHasbp-20251015.xsd
XBRL SCHEMA FILE
- EX-101.DEFasbp-20251015_def.xml
XBRL DEFINITION FILE
- EX-101.LABasbp-20251015_lab.xml
XBRL LABEL FILE
- EX-101.PREasbp-20251015_pre.xml
XBRL PRESENTATION FILE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001493152-25-018512-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLform8-k_htm.xml
IDEA: XBRL DOCUMENT
Issuer
Aspire Biopharma Holdings, Inc.
CIK 0001847345
Entity typeoperating
IncorporatedCayman Islands
Related Parties
1- filerCIK 0001847345
Filing Metadata
- Form type
- 8-K
- Filed
- Oct 16, 8:00 PM ET
- Accepted
- Oct 17, 5:15 PM ET
- Size
- 258.5 KB